Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases

American Journal of Pathology

Volumn 158, Issue 4, 2001, Pages 1525-1532

  Rickert, Christian H ^a,c   Stäter, Ronald ^a   Kaatsch, Peter ^b   Wassmann, Hansdetlef ^a   Jürgens, Heribert ^a   Dockhorn Dworniczak, Barbara ^c   Paulus, Werner ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; KI 67 ANTIGEN;

ADOLESCENT; ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL PROLIFERATION; CHILD; CHILDHOOD CANCER; CHROMOSOME 1Q; CHROMOSOME ABERRATION; CHROMOSOME MAP; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; INFANT; MALE; PRIORITY JOURNAL; PROGNOSIS; STEREOTAXIC SURGERY; SURVIVAL TIME;

EID: 0035069532     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64103-X     Document Type: Article

References (48)

1. Tumours of the nervous system
2. Chromosomal imbalances in primary lymphomas of the central nervous system
3. p53 protein in pediatric malignant astrocytomas: A study of 21 patients
4. Genetics of pediatric central nervous system tumors
5. Pediatric brain tumors: Loss of heterozygosity at 17p and TP53 gene mutations
6. Cytogenetic analysis of 109 pediatric central nervous system tumors
7. Alterations of the TP53 gene in human gliomas
8. Chromosomal abnormalities in 47 pediatric brain tumors
9. Chromosomal characteristics of childhood brain tumors
10. PTEN gene mutations are seen in high-grade but not in low-grade gliomas
11. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas
12. Genetic alterations in pediatric high-grade astrocytomas
13. Cytogenetics
14. Deletion of chromosome arm 17p DNA sequences in pediatric high-grade and juvenile pilocytic astrocytomas
15. Mutations and immunohistochemistry of p53 and proliferation markers in astrocytic tumors of childhood
16. Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens
17. Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas
18. Establishment and characterization of a human cell line from paediatric cerebellar glioblastoma multiforme
19. Age-related nonrandom chromosomal abnormalities in human lowgrade astrocytomas
20. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses
21. Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas
22. Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization
23. Chromosomal aberrations detected by comparative genomic hybridization (CGH) in human astrocytic tumors
24. Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization
25. Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomie hybridization
26. Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade
27. Detection of complex genetic alterations in human glioblastoma multiforme using comparative genomic hybridization
28. Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells
29. Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades
30. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas
31. Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas
32. Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma
33. Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours
34. Common regions of deletion on chromosome 22q12.3q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade
35. Amplification and expression of cyclin D genes (CCDN1, CCDN2, CCDN3) in human malignant gliomas
36. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours
37. MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells
38. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter
39. Proliferation index as a predictor of prognosis in malignant gliomas of childhood
40. MIB-1 labeling index in nonpilocytic astrocytoma of childhood: A study of 101 cases
41. Postoperative chemotherapy and delayed radiation in children less than 3 years of age with malignant brain tumors
42. Survival of infants with malignant astrocytomas: A report from the Childrens Cancer Group
43. Supratentorial malignant gliomas in childhood: A single institution perspective
44. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood
45. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or bcl-2 genes
46. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
47. Incidence of p14ARF gene deletion in high-grade adult and pediatric astrocytomas